MedTrace Logo

The Treatment Preferences of Women Diagnosed With Ovarian Cancer

NCT03367260 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 115

Last updated 2019-06-27

No results posted yet for this study

Summary

The primary objective of this study is to apply best-practice stated-preference methods to quantify the extent to which women with ovarian cancer accept the risks, side effects, and out-of-pocket costs associated with treatment in return for progression-free survival benefit afforded by a treatment, regardless of whether there is an overall survival benefit.

Conditions

Interventions

OTHER

Preference Elicitation

Survey of patient preferences for treatment

Sponsors & Collaborators

Principal Investigators

  • Laura Havrilesky, MD · Duke University

Eligibility

Min Age
18 Years
Max Age
89 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-10-19
Primary Completion
2019-01-04
Completion
2019-01-04

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03367260 on ClinicalTrials.gov